{
    "Trade/Device Name(s)": [
        "One Step Pregnancy Test"
    ],
    "Submitter Information": "SPD Swiss Precision Diagnostics GmbH",
    "510(k) Number": "K210341",
    "Predicate Device Reference 510(k) Number(s)": [
        "K012215"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "December 1, 2021",
    "Summary Letter Received Date": "December 10, 2021",
    "Submission Date": "March 9, 2022",
    "Regulation Number(s)": [
        "21CFR862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (hCG) Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Human chorionic gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Clean dry container"
    ],
    "Instrument(s)/Platform(s)": [
        "Cassette with lateral flow strip"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatographic sandwich assay",
        "Visual interpretation"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow testing"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for One Step Pregnancy Test, a lateral flow immunoassay for qualitative detection of hCG in urine for home pregnancy determination.",
    "Indications for Use Summary": "An over-the-counter lateral flow immunoassay for qualitative detection of hCG in urine to aid in early detection of pregnancy, intended for home use from 4 days before the expected period.",
    "fda_folder": "Clinical Chemistry"
}